Results 41 to 50 of about 25,629 (167)

Anti-VP1 and anti-VP2 antibodies detected by immunofluorescence assays in patients with acute human parvovirus B19 infection

open access: yesMemorias do Instituto Oswaldo Cruz, 2001
Acute human parvovirus B19 infection is followed by an antibody response to the structural proteins of the viral capsid (VP1 and VP2). We used 80 sera collected from 58 erythema infectiosum and 6 transient aplastic crisis patients to test IgM and IgG ...
Renata FA Pereira   +3 more
doaj   +1 more source

Seroepidemiological Study of Parvovirus B19 Infection Among Pregnant Women Attending Ayatollah Rohani Hospital in Babol, Iran: A Cross‐Sectional Study

open access: yesHealth Science Reports, Volume 8, Issue 11, November 2025.
ABSTRACT Background and Aims Parvovirus B19 is a common viral pathogen associated with a variety of clinical manifestations, including significant complications during pregnancy such as fetal anemia, miscarriage, and hydrops fetalis. Determining the seroprevalence of B19‐specific antibodies in pregnant women is essential for assessing population ...
Zeinab Darbandi   +9 more
wiley   +1 more source

Parvovirus: Conservative management of fetal anemia and hydrops

open access: yesActa Obstetricia et Gynecologica Scandinavica, Volume 104, Issue 11, Page 2028-2037, November 2025.
The 2024 rise in congenital parvovirus infections has created substantial demand on fetal medicine services, with an influx of referrals for surveillance and treatment of suspected anemia and hydrops. This review outlines the role of intrauterine transfusion while also describing cases of spontaneous fetal recovery under close monitoring.
Lyndsay Creswell   +8 more
wiley   +1 more source

Parvovirus B19‐associated myocarditis in children: A systematic review of clinical features, management and outcomes

open access: yesEuropean Journal of Clinical Investigation, Volume 55, Issue 11, November 2025.
This systematic review summarizes clinical features, diagnostic strategies and outcomes of paediatric myocarditis associated with Parvovirus B19. Affected children are typically under 3 years old and often present with fulminant symptoms, severe cardiac dysfunction and a high need for ICU‐level support or mechanical circulatory assistance.
Giacomo Veronese   +5 more
wiley   +1 more source

Classical Juvenile Pityriasis Rubra Pilaris Treated With Secukinumab: Case Report and a Review of Biological Treatments in the Pediatric Population

open access: yesPediatric Dermatology, Volume 42, Issue 6, Page 1214-1220, November/December 2025.
ABSTRACT Pityriasis rubra pilaris (PRP) is a rare, chronic papulosquamous disorder with limited treatment options in pediatric patients. We report the case of a 9‐year‐old boy with juvenile PRP (type III), who achieved complete disease remission after treatment with secukinumab, an IL‐17A inhibitor, following initial therapeutic resistance to topical ...
Zeno Fratton   +2 more
wiley   +1 more source

Analysis of the Incidence and Severity of Cellulitis During the COVID‐19 Pandemic in Japan

open access: yesThe Journal of Dermatology, Volume 52, Issue 10, Page 1512-1518, October 2025.
ABSTRACT During the COVID‐19 pandemic, a decline in various infectious disease cases was observed. However, changes in dermatological infectious diseases, particularly cellulitis, and the potential impact of delayed consultations on severe cases have not been fully explored.
Tomoyo Sato   +4 more
wiley   +1 more source

Skimager for the objective erythema estimation in atopic dogs [PDF]

open access: yes, 2020
In this study, the severity of canine skin erythema was assessed objectively for the first time. Atopic dermatitis (AD) is a common canine inflammatory and pruritic skin disease associated with an allergic reaction to exogenous allergens.
Janis Spigulis   +7 more
core   +1 more source

Splenic infarcts as a rare manifestation of parvovirus B19 infection

open access: yesIDCases, 2016
Introduction: Human parvovirus B19 is a DNA virus most known for causing erythema infectiosum in children, and polyarthropathy or transient aplastic crisis in adults. However, various unusual clinical manifestations have also been reported in association
Georgios Kranidiotis   +5 more
doaj   +1 more source

Comprehensive surveillance data suggest a prominent role of parvovirus B19 infection in Belarus and the presence of a third subtype within subgenotype 1a

open access: yesScientific Reports, 2021
Human parvovirus B19 (B19V) infection is not notifiable in Belarus and its most common clinical presentation erythema infectiosum (EI) is often difficult to distinguish from other exanthematous diseases.
Marina A. Yermalovich   +6 more
doaj   +1 more source

Is parvovirus B19 infection upsurge in 2023–2024 associated with adverse pregnancy outcome?

open access: yesUltrasound in Obstetrics &Gynecology, Volume 66, Issue 3, Page 307-313, September 2025.
ABSTRACT Objective A surge in parvovirus B19 infections has been reported in 2023–2024 across Europe and the USA, raising concerns about the associated perinatal risks. The aim of this study was to compare perinatal outcomes following maternal parvovirus B19 infection during the 2023–2024 period with those from a pre‐2023 cohort.
S. Prasad   +22 more
wiley   +1 more source

Home - About - Disclaimer - Privacy